J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e164

Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040)

Ouh¹, YT; Park, JJ; Kang, M; Kim, M; Song, JY; Shin, SJ; Shim, SH; Yoo, HJ; Lee, M; Lee, SJ; Shin, W; Chong, GO; Choi, MC; Choi, CH; Min, KJ

GYNECOL ONCOL 2021 10.1016/j.ygyno.2021.02.009

Metabolic syndrome and persistent cervical human papillomavirus infection

Lee¹, J; Kim, HS; Kim, K; Bae, DS; Kim, BG; Choi, CH

FRONT ONCOL 2021 10.3389/fonc.2021.670214

Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix

Jung¹, JH; Noh, JJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY

J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e31

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)

Lee¹, YJ; Lim, MC; Kim, BG; Ngoi, NY; Choi, CH; Park, SY; Tan, DSP; Go, YJ; Lee, JY

TAIWAN J OBSTET GYNECOL 2021 10.1016/j.tjog.2020.11.020

Vulvar epithelioid sarcoma: A case report with literature review

Noh¹, JJ; Jeon, JE; Jung, H; Kim, HS; Lee, YY; Choi, CH; Lee, JW

J CLIN MED 2020 10.3390/jcm9113471

Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type

Kang¹, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH

YONSEI MED J 2020 10.3349/ymj.2020.61.11.935

Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer

Shin¹, W; Noh, JJ; Seo, SS; Kang, S; Choi, CH; Park, SY; Kim, BG; Lim, MC

CURR PROB CANCER 2020 10.1016/j.currproblcancer.2020.100557

Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer

Choi¹, HJ; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Bae, JH; Bae, DS; Kim, BG

J CLIN MED 2020 10.3390/jcm9092960

The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer

Noh¹, JJ; Lim, MC; Kim, MH; Kim, YH; Song, ES; Seong, SJ; Suh, DH; Lee, JM; Lee, C; Choi, CH

FRONT ONCOL 2020 10.3389/fonc.2020.583515

Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor

Kang¹, JH; Noh, JJ; Jeong, SY; Shim, JI; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, HS; Kim, TJ

INT J GYNECOL CANCER 2020 10.1136/ijgc-2020-001604

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)

Ngoi¹, NYL; Heong, V; Ow, S; Chay, WY; Kim, HS; Choi, CH; Goss, G; Goh, JC; Tai, BC; Lim, DGZ; Kaliaperumal, N; Au, VB; Connolly, JE; Kim, JW; Friedlander, M; Kim, K; Tan, DSP

GYNECOL ONCOL 2020 10.1016/j.ygyno.2020.02.017

Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer

Choi¹, CH; Chung, JY; Kang, JH; Paik, ES; Lee, YY; Park, W; Byeon, SJ; Chung, EJ; Kim, BG; Hewitt, SM; Bae, DS

CANCER RES TREAT 2020 10.4143/crt.2019.509

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients

Cho¹, MA; Jeong, SY; Sohn, I; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Choi, CH

J CLIN MED 2020 10.3390/jcm9041137

Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis

Kim¹, J; Chung, JY; Hwang, JR; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM

Front Oncol 2020 10.3389/fonc.2020.00451

Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer

Paik¹, ES; Baek, SH; Kang, JH; Jeong, SY; Kim, MS; Kim, WY; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, TJ

CANCER RES TREAT 2020 10.4143/crt.2019.328

Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status

Jeong¹, SY; Park, H; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

J OBSTET GYNAECOL RE 2020 10.1111/jog.14171

Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study

Kim¹, SI; Choi, CH; Kim, K; Hong, DH; Park, JY; Kwon, BS; Lee, KH; Hong, DG; Shin, SJ; Park, SI; Kim, YH; Lee, SH; Lee, S; Hong, JH; Lee, JY; Kim, YB; No, JH; Suh, DH

GYNECOL ONCOL 2020 10.1016/j.ygyno.2019.11.004

CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer

Kim¹, J; Cho, YJ; Ryu, JY; Hwang, I; Han, HD; Ahn, HJ; Kim, WY; Cho, H; Chung, JY; Hewitt, SM; Kim, JH; Kim, BG; Bae, DS; Choi, CH; Lee, JW

CANCER RES TREAT 2020 10.4143/crt.2019.124

Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)

Paik¹, ES; Lim, MC; Kim, MH; Kim, YH; Song, ES; Seong, SJ; Suh, DH; Lee, JM; Lee, C; Choi, CH

J CLIN MED 2020 10.3390/jcm9010147

Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer

Choi¹, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG

Cancer Res Treat. 2019 Aug 5. doi: 10.4143/crt.2019.124. [Epub ahead of print]

Prognostic Model for Survival and Recurrence in Patients with Early Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)

Paik ES¹, Lim MC, Kim MH, Kim YH, Song ES, Seong SJ, Suh DH, Lee JM, Lee C, Choi CH.

J OVARIAN RES 2019 10.1186/s13048-019-0602-5

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

Jeong¹, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY

EUR RADIOL 2019 10.1007/s00330-019-06204-w

Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy

Gu¹, KW; Kim, CK; Choi, CH; Yoon, YC; Park, W

J CLIN MED 2019 10.3390/jcm8111920

Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study

Paik¹, ES; Lee, YJ; Lee, JY; Shin, W; Park, SY; Kim, SI; Kim, JW; Choi, CH; Kim, BG

J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e112

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Lee¹, JY; Kim, JW; Lim, MC; Kim, S; Kim, HS; Choi, CH; Yi, JY; Park, SY; Kim, BG; Nam, EJ; Kim, SW; Eoh, KJ; Lee, YJ; Roh, J; Kim, HM; Rae, DS; Lee, JW; Kim, TJ; Lee, YY; Choi, EH; Song, S; Kim, HS; Lee, M; Kim, SI; Lee, EJ; Kwon, SI; Shin, W; Seo, SS; Kang, S; Kim, MS; Kim, JS; Joung, J; Chung, J

SCI REP-UK 2019 10.1038/s41598-019-51959-3

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer

Lee¹, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW

GYNECOL ONCOL 2019 10.1016/j.ygyno.2019.06.023

Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028)

Paik¹, ES; Lim, MC; Kim, MH; Kim, YH; Song, ES; Seong, SJ; Suh, DH; Lee, JM; Lee, C; Choi, CH

JPN J CLIN ONCOL 2019 10.1093/jjco/hyz085

An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION

Lee¹, JY; Yi, JY; Kim, HS; Lim, J; Kim, S; Nam, BH; Kim, HS; Kim, JW; Choi, CH; Kim, BG

EUR J GYNAECOL ONCOL 2019 10.12892/ejgo4827.2019

Mesonephric adenocarcinoma treated with paclitaxel-carboplatin adjuvant chemotherapy: a case report

Noh¹, JJ; Jung, H; Choi, CH

J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e65

Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods

Paik¹, ES; Lee, JW; Park, JY; Kim, JH; Kim, M; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Seo, SW

J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e11

Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?

Kim¹, J; Chang, Y; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

CANCER RES TREAT 2019 10.4143/crt.2017.361

Development and Validation of Ovarian Symptom Index-18 and Neurotoxcity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Lee¹, M; Lee, Y; Kim, K; Park, EY; Lim, MC; Kim, JS; Kim, HS; Kim, YB; Kim, YM; Joo, J; Park, SY; Choi, CH; Kim, JH

Front Oncol. 2018 Oct 23;8:465. doi: 10.3389/fonc.2018.00465. eCollection 2018.

Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma

Jihye Kim¹, Joon-Yong Chung, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi, Stephen M Hewitt

Tumour Biol. 2018 Oct;40(10):1010428318808678. doi: 10.1177/1010428318808678.

Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma

Joon Seon Song¹, Joo Mi Yi, Hanbyoul Cho, Chel Hun Choi, Yoonho Park, Eun Joo Chung, Jaewhan Song, Joon-Yong Chung, Seung-Mo Hong

Front Oncol 2018 10.3389/fonc.2018.00465

Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma

Kim¹, J; Chung, JY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM

EUR J OBSTET GYN R B 2018 10.1016/j.ejogrb.2018.06.034

The role of appendectomy in patients with mucinous borderline ovarian tumors

Song¹, T; Kim, MK; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS

INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001316

Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix A Retrospective Analysis

Choi¹, HJ; Paik, ES; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Bae, DS; Kim, BG

SCI REP-UK 2018 10.1038/s41598-018-30582-8

Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer

Choi¹, CH; Kang, TH; Song, JS; Kim, YS; Chung, EJ; Ylaya, K; Kim, S; Koh, SS; Chung, JY; Kim, JH; Hewitt, SM

ONCOGENE 2018 10.1038/s41388-018-0267-3

Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt/beta-catenin signaling

Lee¹, HK; Lee, EW; Seo, J; Jeong, M; Lee, SH; Kim, SY; Jho, EH; Choi, CH; Chung, JY; Song, J

INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001270

Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study

Kim¹, M; Choi, C; Kim, K; Lim, MC; Park, JY; Hong, JH; Lee, M; Paek, J; Seoung, J; Lee, S; Lee, TS

CELL DEATH DIFFER 2018 10.1038/s41418-018-0072-0

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF

Ko¹, A; Han, SY; Choi, CH; Cho, H; Lee, MS; Kim, SY; Song, JS; Hong, KM; Lee, HW; Hewitt, SM; Chung, JY; Song, J

CANCER RES 2018 10.1158/0008-5472.CAN-17-2325

Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis

Oh¹, SJ; Cho, H; Kim, S; Noh, KH; Song, KH; Lee, HJ; Woo, SR; Kim, S; Choi, CH; Chung, JY; Hewitt, SM; Kim, JH; Baek, S; Lee, KM; Yee, C; Park, HC; Kim, TW

CANCER RES TREAT 2018 10.4143/crt.2017.104

Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer

Paik¹, ES; Choi, HJ; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e18

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis

Paik¹, ES; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Lee, JW

GYNECOL OBSTET INVES 2018 10.1159/000475817

Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis?

Song¹, T; Lee, DH; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Lee, JW; Bae, DS; Kim, BG

J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e13

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer

Paik¹, ES; Kim, JH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

CANCER RES TREAT 2017 10.4143/crt.2016.322

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies

Heo¹, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW

CANCER RES 2017 10.1158/0008-5472.CAN-17-0072

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells

Song¹, KH; Choi, CH; Lee, HJ; Oh, SJ; Woo, SR; Hong, SO; Noh, KH; Cho, H; Chung, EJ; Kim, JH; Chung, JY; Hewitt, SM; Baek, S; Lee, KM; Yee, C; Son, M; Mao, CP; Wu, TC; Kim, TW

CANCER RES TREAT 2017 10.4143/crt.2016.034

Proton. Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer

Song¹, T; Jeon, HK; Hong, JE; Choi, JJ; Kim, TJ; Choi, CH; Bae, DS; Kim, BG; Lee, JW

SCI REP-UK 2017 10.1038/s41598-017-06510-7

The anti-cancer effects of itraconazole in epithelial ovarian cancer

Choi¹, CH; Ryu, JY; Cho, YJ; Jeon, HK; Choi, JJ; Ylaya, K; Lee, YY; Kim, TJ; Chung, JY; Hewitt, SM; Kim, BG; Bae, DS; Lee, JW

CANCER RES TREAT 2017 10.4143/crt.2016.282

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer

Paik¹, ES; Sohn, I; Baek, SY; Shim, M; Choi, HJ; Kim, TJ; Choi, CH; Lee, JW; Kim, BG; Lee, YY; Bae, DS

Eur J Cancer Prev. 2017 Jan;26(1):78-85.

The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis

Song T1¹, Choi CH, Kim MK, Kim ML, Yun BS, Seong SJ.

Cancer Res. 2017 Jan 15;77(2):343-354. doi: 10.1158/0008-5472.CAN-16-0613. Epub 2016 Oct 28.

Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF

Han SY1¹, Ko A1, Kitano H2,3, Choi CH2,4, Lee MS1, Seo J1, Fukuoka J5, Kim SY6, Hewitt SM2, Chung JY2, Song J7.

Oncogenesis. 2017 Jan 16;6(1):e285. doi: 10.1038/oncsis.2016.87.

API5 confers cancer stem cell-like properties through the FGF2-NANOG axis

Song KH1¹,2,3, Cho H4,5,6, Kim S7, Lee HJ1,2,3, Oh SJ1,2,3, Woo SR1,2, Hong SO1,2, Jang HS1,2,3, Noh KH1,2, Choi CH4,8, Chung JY4, Hewitt SM4, Kim JH5,6, Son M9, Kim SH10, Lee BI11, Park HC7, Bae YK12, Kim TW1,2,3.

J Gynecol Oncol. 2017 Jan;28(1):e5. doi: 10.3802/jgo.2017.28.e5. Epub 2016 Aug 19.

Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy

Lee M1¹, Choi CH2, Chun YK3, Kim YH4, Lee KB5, Lee SW6, Shim SH7, Song YJ8, Roh JW9, Chang SJ10, Lee JM11.

Sci Rep. 2016 Dec 5;6:38502. doi: 10.1038/srep38502.

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma

Kim HJ1¹, Yoon A2, Ryu JY2, Cho YJ2, Choi JJ2, Song SY3, Bang H3, Lee JS4, Cho WC5, Choi CH2, Lee JW2,6,7, Kim BG2, Bae DS2.

Anticancer Res. 2016 Dec;36(12):6381-6388.

Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells

Lee YY1¹, Jeon HK2, Lee J3, Hong JE2, Do IG4, Choi CH2, Kim TJ2, Kim BG2, Bae DS2, Kim YC3, Lee JW5.

Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658.

Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer

Paik ES¹, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.

Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647. doi: 10.1111/ajo.12529. Epub 2016 Sep 9.

Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery

Paik ES1¹, Lee YY1, Shim M1, Choi HJ1, Kim TJ1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.

Gynecol Oncol. 2016 Nov;143(2):252-257. doi: 10.1016/j.ygyno.2016.08.321. Epub 2016 Aug 25.

Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis

Paik ES1¹, Shim M1, Choi HJ1, Lee YY2, Kim TJ1, Lee JW1, Kim BG1, Bae DS1, Choi CH3.

Oncotarget. 2016 Nov 22;7(47):77052-77070. doi: 10.18632/oncotarget.12784.

Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer

Kwon M1¹, Kim JH2,3, Rybak Y1, Luna A1, Choi CH4,5, Chung JY5, Hewitt SM5, Adem A1, Tubridy E1, Lin J6, Libutti SK1.

Lab Invest. 2016 Oct;96(10):1116-27. doi: 10.1038/labinvest.2016.90. Epub 2016 Aug 22.

A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue

Chung JY1¹, Choi J2, Sears JD1, Ylaya K1, Perry C1,3, Choi CH1,4, Hong SM5, Cho H1,6, Brown KM2, Hewitt SM1.

Arch Gynecol Obstet. 2016 Jan;293(1):157-62. doi: 10.1007/s00404-015-3801-3. Epub 2015 Jul 9.

Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum

Yoon G1¹, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Kim BG3, Bae DS3, Hwang JH4, Lee JW5.

J Gynecol Oncol. 2016 Sep;27(5):e46. doi: 10.3802/jgo.2016.27.e46. Epub 2016 May 9.

Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer

Paik ES1¹, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.

Int J Gynecol Cancer. 2016 Sep;26(7):1252-7. doi: 10.1097/IGC.0000000000000762.

Long-term Outcomes of MRI Stage IIB Cervical Cancer

Yoon A1¹, Park JJ, Park BK, Lee YY, Paik ES, Choi CH, Kim TJ, Kim CK, Lee JW, Bae DS, Kim BG.

BMC Cancer. 2016 Jul 11;16:448. doi: 10.1186/s12885-016-2459-y.

Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer

Choi CH1¹,2, Chung JY1, Chung EJ3, Sears JD1, Lee JW2, Bae DS4, Hewitt SM5.

J Histochem Cytochem. 2016 Jul;64(7):425-40. doi: 10.1369/0022155416649579. Epub 2016 May 24.

A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications

Perry C1¹, Chung JY1, Ylaya K1, Choi CH1, Simpson A1, Matsumoto KT1, Smith WA1, Hewitt SM2.

J Gynecol Oncol. 2016 Jul;27(4):e38. doi: 10.3802/jgo.2016.27.e38. Epub 2016 Apr 18.

Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer

Choi HJ1¹, Lee S2, Park BK3, Kim TJ1, Kim CK2, Park JJ2, Choi CH1, Lee YY1, Lee JW1, Bae DS1, Kim BG1.

J Transl Med. 2016 May 6;14(1):124. doi: 10.1186/s12967-016-0874-0.

Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients

Choi CH1¹,2, Chung JY1, Kim JH3, Kim BG4, Hewitt SM5.

J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24.

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer

Paik ES1¹, Lee YY1, Kim TJ1, Choi CH1, Lee JW2, Kim BG1, Bae DS1.

JSLS. 2016 Apr-Jun;20(2). pii: e2016.00001. doi: 10.4293/JSLS.2016.00001

Retroperitoneal Approach in Single-Port Laparoscopic Hysterectomy

Kim TH1¹, Kim CJ1, Kim TJ2, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.

Radiology. 2016 Mar;278(3):925-35. doi: 10.1148/radiol.2015150608. Epub 2015 Aug 27.

Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation

Kim YS1¹, Lee JW1, Choi CH1, Kim BG1, Bae DS1, Rhim H1, Lim HK1.

Oncotarget. 2015 Sep 29;6(29):26746-56. doi: 10.18632/oncotarget.4818.

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

Kim HS1¹, Yoon G2, Ryu JY3, Cho YJ3, Choi JJ3, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3,5.

J Gynecol Oncol. 2015 Jul;26(3):222-6. doi: 10.3802/jgo.2015.26.3.222.

Robotic high para-aortic nymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients

Kim TJ1¹, Yoon G2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG3.

Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:48-51. doi: 10.1016/j.ejogrb.2015.04.014. Epub 2015 May 1.

A prospective comparative study of cosmetic satisfaction for three different surgical approaches

Song T1¹, Park JY2, Kim TJ3, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.

Int J Gynecol Cancer. 2015 Jul;25(6):1051-7. doi: 10.1097/IGC.0000000000000407.

Perioperative Outcomes of Radical Trachelectomy in Early-Stage Cervical Cancer Vaginal Versus Laparoscopic Approaches

Yoon A1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.

Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:26-30. doi: 10.1016/j.ejogrb.2015.04.005. Epub 2015 Apr 16.

The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ

Song T1¹, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.

Int J Cancer. 2015 Jul 1;137(1):221-9. doi: 10.1002/ijc.29362. Epub 2014 Dec 8.

Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer

Lee JW1¹, Ryu JY, Yoon G, Jeon HK, Cho YJ, Choi JJ, Song SY, Do IG, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.

Hum Pathol. 2015 Jun;46(6):884-93. doi: 10.1016/j.humpath.2015.02.016. Epub 2015 Mar 11.

Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients

Choi CH1¹, Chung JY2, Park HS3, Jun M2, Lee YY4, Kim BG5, Hewitt SM6.

Int J Clin Exp Pathol. 2015 May 1;8(5):5318-26. eCollection 2015.

Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis

Kim HS1¹, Yoon G2, Lee YY3, Kim TJ3, Choi CH3, Lee JW3, Kim BG3, Bae DS3, Song SY4.

Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404.

Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy

Yoon A1¹, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.

Int J Clin Exp Pathol. 2015 May 1;8(5):5688-94. eCollection 2015.

Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands

Yoon G1¹, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3.

Diagn Pathol. 2015 May 29;10:53. doi: 10.1186/s13000-015-0290-4.

Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array

Braunschweig T1¹,2, Chung JY3, Choi CH4,5, Cho H6,7, Chen QR8,9, Xie R10, Perry C11,12, Khan J13, Hewitt SM14.

Taiwan J Obstet Gynecol. 2015 Apr;54(2):150-4. doi: 10.1016/j.tjog.2014.05.005.

Is laparoendoscopic single-site surgery (LESS) retroperitoneal hysterectomy feasible: Surgical outcomes of the initial 27 cases

Kim TH1¹, Kim TJ2, Yoo HN1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.

BMC Cancer. 2015 Dec 26;15:1015. doi: 10.1186/s12885-015-2015-1.

Clinical significance of OCT4 and SOX2 protein expression in cervical cancer

Kim BW1¹,2, Cho H3, Choi CH4,5, Ylaya K6, Chung JY7, Kim JH8, Hewitt SM9.

Oncotarget. 2015 Oct 27;6(33):35040-50. doi: 10.18632/oncotarget.5319.

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma

Lee YY1¹, Jeon HK1, Hong JE1, Cho YJ1, Ryu JY1, Choi JJ1, Lee SH2, Yoon G3, Kim WY4, Do IG5, Kim MK6, Kim TJ1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.

Pathobiology. 2015;82(5):203-11. doi: 10.1159/000434726. Epub 2015 Aug 25.

Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer

Choi CH1¹, Chung JY, Cho H, Kitano H, Chang E, Ylaya K, Chung EJ, Kim JH, Hewitt SM.

Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:38-42. doi: 10.1016/j.ejogrb.2014.10.001. Epub 2014 Oct 14.

Borderline ovarian tumor in women aged >= 65 years: impact on recurrence and survival

Song T1¹, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.

J Gynecol Oncol. 2015 Jan;26(1):62-7. doi: 10.3802/jgo.2015.26.1.62.

Single-site robotic surgery in gynecologic cancer: a pilot study

Yoo HN1¹, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.

Int J Gynecol Cancer. 2014 Sep;24(7):1299-305. doi: 10.1097/IGC.0000000000000197.

Prognostic Factors Influencing Decisions About Surgical Treatment of Villoglandular Adenocarcinoma of the Uterine Cervix

Kim HJ1¹, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.

Am J Obstet Gynecol. 2014 Aug;211(2):168.e1-7. doi: 10.1016/j.ajog.2014.02.032. Epub 2014 Mar 4.

Postoperative outcomes of MR-invisible stage IB1 cervical cancer

Park JY1¹, Lee JW1, Park BK2, Lee YY1, Choi CH1, Kim TJ1, Bae DS1, Kim BG1, Park JJ3, Park SY3, Kim CK3.

Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:58-61. doi: 10.1016/j.ejogrb.2014.01.004. Epub 2014 Jan 17.

Laparoendoscopic single-site (LESS) myomectomy: characteristics of the appropriate myoma

Yoon A1¹, Kim TJ1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG2.

J Laparoendosc Adv Surg Tech A. 2014 Apr;24(4):254-9. doi: 10.1089/lap.2013.0507. Epub 2014 Feb 25.

Comparison of Laparoendoscopic Single-Site Hysterectomies: Laparoscopic Hysterectomy with Some Vaginal Component Versus Laparoscopically Assisted Vaginal Hysterectomy

Kim TJ1¹, Song T, Choi CH, Lee JW, Bae DS, Kim BG.

Clin Cancer Res. 2014 Feb 1;20(3):565-75. doi: 10.1158/1078-0432.CCR-13-1271. Epub 2013 Nov 6.

Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma

Park YA1¹, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S30-4. doi: 10.1097/IGC.0000000000000293.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Small Cell Cancers

Reed NS1¹, Pautier P, Avall-Lundqvist E, Choi CH, du Bois A, Friedlander M, Fyles A, Kichenadasse G, Provencher DM, Ray-Coquard I.

Radiology. 2014 Nov;273(2):462-71. doi: 10.1148/radiol.14132719. Epub 2014 Jul 1.

Uterine Fibroids: Semiquantitative Perfusion MR Imaging Parameters Associated with the Intraprocedural and Immediate Postprocedural Treatment Efficiencies of MR Imaging-guided High-Intensity Focused Ultrasound Ablation

Kim YS1¹, Kim BG, Rhim H, Bae DS, Lee JW, Kim TJ, Choi CH, Lee YY, Lim HK.

Int J Gynecol Cancer. 2014 Oct;24(8):1466-73. doi: 10.1097/IGC.0000000000000232.

Robotic Versus Laparoscopic Radical Hysterectomy in Cervical Cancer Patients A Matched-Case Comparative Study

Kim TH1¹, Choi CH, Choi JK, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2014 Oct;135(1):108-17. doi: 10.1016/j.ygyno.2014.06.031. Epub 2014 Jul 9.

Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma

Park YA1¹, Choi CH1, Do IG2, Song SY2, Lee JK3, Cho YJ1, Choi JJ1, Jeon HK1, Ryu JY1, Lee YY1, Kim TJ1, Bae DS1, Lee JW4, Kim BG5.

Int J Gynecol Cancer. 2014 Jan;24(1):107-12. doi: 10.1097/IGC.0000000000000015.

Bone Metastasis in Primary Endometrial Carcinoma Features, Outcomes, and Predictors

Yoon A1¹, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2014 Jan;132(1):70-5. doi: 10.1016/j.ygyno.2013.10.029. Epub 2013 Oct 31.

Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases

Yoon A1¹, Park JY2, Park JY1, Lee YY1, Kim TJ1, Choi CH1, Bae DS1, Kim BG1, Lee JW3, Nam JH4.

Taiwan J Obstet Gynecol. 2014 Sep;53(3):343-7. doi: 10.1016/j.tjog.2013.10.041.

Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings

Kim HJ1¹, Choi CH2, Lee YY2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.

J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):580-5. doi: 10.1016/j.jmig.2013.12.096. Epub 2013 Dec 31.

Surgical Outcomes of a New Approach to Laparoscopic Myomectomy: Single-Port and Modified Suture Technique

Choi CH1¹, Kim TH1, Kim SH1, Choi JK1, Park JY1, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Kim BG1, Bae DS2.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1179-88. doi: 10.1007/s00432-014-1658-7. Epub 2014 Mar 27.

Meta-analysis of the effects of beta blocker on survival time in cancer patients

Choi CH1¹, Song T, Kim TH, Choi JK, Park JY, Yoon A, Lee YY, Kim TJ, Bae DS, Lee JW, Kim BG.

Support Care Cancer. 2014 May;22(5):1181-7. doi: 10.1007/s00520-013-2070-6. Epub 2013 Dec 12.

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

Choi CH1¹, Kim MK, Park JY, Yoon A, Kim HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.

Gynecol Obstet Invest. 2013;76(4):241-7. doi: 10.1159/000356072. Epub 2013 Nov 1.

Endocervical-Like versus intestinal-Type Mucinous Borderline Ovarian Tumors: A Large Retrospective Series Focusing on the Clinicopatholigic Characteristics

Song T1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Sung CO, Song SY, Bae DS, Kim BG.

Int J Gynecol Cancer. 2013 Sep;23(7):1311-7. doi: 10.1097/IGC.0b013e31829da127.

Contributing Factors for Bone Metastasis in Uterine Cervical Cancer

Yoon A1¹, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Hum Pathol. 2013 Jun;44(6):1017-23. doi: 10.1016/j.humpath.2012.08.024. Epub 2013 Jan 3.

Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary

Choi CH1¹, Sung CO, Kim HJ, Lee YY, Song SY, Song T, Kim J, Kim TJ, Lee JW, Bae DS, Kim BG.

Cancer Genet. 2013 May;206(5):145-53. doi: 10.1016/j.cancergen.2013.04.002. Epub 2013 May 29.

Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma

Sung CO1¹, Choi CH, Ko YH, Ju H, Choi YL, Kim N, Kang SY, Ha SY, Choi K, Bae DS, Lee JW, Kim TJ, Song SY, Kim BG.

Ann Surg Oncol. 2012 Nov;19(12):3839-48. doi: 10.1245/s10434-012-2406-3. Epub 2012 May 30.

Comparison of Laparoscopic-Assisted Radical Vaginal Hysterectomy and Laparoscopic Radical Hysterectomy in the Treatment of Cervical Cancer

Choi CH1¹, Lee JW, Lee YY, Kim HJ, Song T, Kim MK, Kim TJ, Kim BG, Bae DS.

Gynecol Oncol. 2012 Jul;126(1):124-31. doi: 10.1016/j.ygyno.2012.04.020. Epub 2012 Apr 21.

Angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells

Choi CH1¹, Park YA, Choi JJ, Song T, Song SY, Lee YY, Lee JW, Kim TJ, Kim BG, Bae DS.

J Sex Med. 2012 Jun;9(6):1697-704. doi: 10.1111/j.1743-6109.2012.02723.x. Epub 2012 Apr 30.

Sexual Function after Surgery for Early-Stage Cervical Cancer: Is There a Difference in It According to the Extent of Surgical Radicality

Song T1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.

Br J Cancer. 2012 Jun 26;107(1):91-9. doi: 10.1038/bjc.2012.217. Epub 2012 May 29.

Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival

Choi CH1¹, Choi JJ, Park YA, Lee YY, Song SY, Sung CO, Song T, Kim MK, Kim TJ, Lee JW, Kim HJ, Bae DS, Kim BG.

Ann Surg Oncol. 2012 Jun;19(6):1973-9. doi: 10.1245/s10434-011-2148-7. Epub 2011 Dec 20.

Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study

Kim HS1¹, Choi CH, Lim MC, Chang SJ, Kim YB, Kim MA, Kim TJ, Park SY, Kim BG, Song YS, Bae DS, Kim JW.

Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030. Epub 2012 Jan 28.

Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer

Song T1¹, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.

Gynecol Oncol. 2012 Jan;124(1):92-7. doi: 10.1016/j.ygyno.2011.09.034. Epub 2011 Oct 19.

Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level

Lee YY1¹, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1252-7. doi: 10.1016/j.ijrobp.2010.07.2006. Epub 2010 Nov 13.

A MATCHED-CASE COMPARISON TO EXPLORE THE ROLE OF CONSOLIDATION CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION IN CERVICAL CANCER

Choi CH1¹, Lee YY, Kim MK, Kim TJ, Lee JW, Nam HR, Huh SJ, Lee JH, Bae DS, Kim BG.

J Gynecol Oncol. 2011 Sep;22(3):203-6. doi: 10.3802/jgo.2011.22.3.203. Epub 2011 Sep 28.

Chemo-resistant choriocarcinoma metastatic to colon cured by low-anterior resection

Ryu JH1¹, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.

Hum Reprod. 2011 Aug;26(8):2008-14. doi: 10.1093/humrep/der119. Epub 2011 Apr 21.

Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours

Song T1¹, Hun Choi C, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2011 Jul;122(1):127-31. doi: 10.1016/j.ygyno.2011.03.021. Epub 2011 Apr 13.

Accuracy of frozen section diagnosis of borderline ovarian tumors

Song T1¹, Choi CH, Kim HJ, Kim MK, Kim TJ, Lee JW, Bae DS, Kim BG.

Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):204-8. doi: 10.1016/j.ejogrb.2011.01.009. Epub 2011 Feb 8.

Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors

Song T1¹, Choi CH, Kim HJ, Lee W, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

J Gynecol Oncol. 2011 Jun 30;22(2):83-8. doi: 10.3802/jgo.2011.22.2.83.

Which is worse: uterine papillary serous carcinomas or carcinosarcomas

Song T1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.

Cancer. 2011 May 15;117(10):2104-11. doi: 10.1002/cncr.25710. Epub 2010 Nov 29.

Phase II Study of Belotecan, a Camptothecin Analogue, in Combination With Carboplatin for the Treatment of Recurrent Ovarian Cancer

Choi CH1¹, Lee YY, Song TJ, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.

Int J Gynecol Cancer. 2011 May;21(4):640-6. doi: 10.1097/IGC.0b013e3182129842.

Fertility-Sparing Surgery for Borderline Ovarian Tumors Oncologic Safety and Reproductive Outcomes

Song T1¹, Choi CH, Park HS, Kim MK, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

J Cancer Res Clin Oncol. 2011 Mar;137(3):463-9. doi: 10.1007/s00432-010-0902-z. Epub 2010 May 13.

Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma adenocarcinoma

Choi CH1¹, Lee JS, Kim SR, Lee YY, Kim CJ, Lee JW, Kim TJ, Lee JH, Kim BG, Bae DS.

Gynecol Oncol. 2011 Mar;120(3):439-43. doi: 10.1016/j.ygyno.2010.11.022. Epub 2010 Dec 8.

A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA

Lee YY1¹, Choi CH, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.

Eur J Obstet Gynecol Reprod Biol. 2010 Dec;153(2):207-10. doi: 10.1016/j.ejogrb.2010.07.038. Epub 2010 Aug 21.

Clinical significance of pmTOR expression in endometrioid endometrial carcinoma

Choi CH1¹, Lee JS, Kim SR, Kim TJ, Lee JW, Kim BG, Bae DS.

J Pediatr Surg. 2010 Oct;45(10):1955-60. doi: 10.1016/j.jpedsurg.2010.06.012.

Pediatric borderline ovarian tumors: a retrospective analysis

Song T1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Int J Gynecol Cancer. 2010 Jul;20(5):798-803.

Peritoneal Tuberculosis A Retrospective Review of 20 Cases and Comparison With Primary Peritoneal Carcinoma

Choi CH1¹, Kim CJ, Lee YY, Kim JS, Song T, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.

J Obstet Gynaecol Res. 2010 Apr;36(2):304-10. doi: 10.1111/j.1447-0756.2009.01131.x.

Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

Choi CH1¹, Song SY, Kang H, Lee YY, Kim CJ, Lee JW, Kim TJ, Kim BG, Lee JH, Bae DS.

Gynecol Oncol. 2010 Mar;116(3):459-63. doi: 10.1016/j.ygyno.2009.11.016. Epub 2009 Dec 8.

Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA)

Lee YY1¹, Choi CH, Kim CJ, Song TJ, Kim MK, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.

BMC Cancer. 2008 Oct 11;8:295. doi: 10.1186/1471-2407-8-295.

Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

Choi CH1¹, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.

Clin Cancer Res. 2008 May 1;14(9):2535-42. doi: 10.1158/1078-0432.CCR-07-1231.

Altered MicroRNA expression in cervical carcinomas

Lee JW1¹, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199-204. Epub 2007 Nov 26.

Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation

Choi CH1¹, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS.

Cancer Lett. 2007 Sep 18;255(1):26-33. Epub 2007 Apr 30.

Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer

Choi CH1¹, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ, Lee JH, Bae DS, Kim BG.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):817-22. Epub 2007 Mar 26.

Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results

Choi CH1¹, Lee JW, Kim TJ, Kim WY, Nam HR, Kim BG, Huh SJ, Lee JH, Bae DS.

Gynecol Oncol. 2007 Jun;105(3):762-8. Epub 2007 Mar 26.

Papillary serous carcinoma in ovaries of normal size: A clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma

Choi CH1¹, Kim TJ, Kim WY, Ahn GH, Lee JW, Kim BG, Lee JH, Bae DS.

Gynecol Oncol. 2007 Jan;104(1):64-9. Epub 2006 Aug 10.

Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma

Choi CH1¹, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.

Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):243-7. Epub 2006 Feb 28.

Expression of CD44 adhesion molecules on human placentae

Choi CH1¹, Roh CR, Kim TJ, Choi YL, Lee JW, Kim BG, Lee JH, Bae DS.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1157-64.

Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix

Choi CH1¹, Kim TJ, Lee SJ, Lee JW, Kim BG, Lee JH, Bae DS.